Sabrina Kamran, Phd, Ca-Am Email & Phone Number

Boston, Ma, Us

Boston, Ma, Us

London, Gb

Evaluated in-licensed technologies from 23 partnerships by liaising with inventing scientists and technology transfer offices to gather product information in order to effectively market these technologies to Ximbio's customersExpanded partnerships in North America by 39%, generating 11 new partnership including new markets in Texas, Florida and Puerto Rico, which resulted in ~3300 tools in-licensed into Ximbio's product portfolio, increasing product portfolio by 58%.Established 9 internship programs, increasing total number by 50% percent in North America for FY 2020. Manage 11 on campus interns.Performed sales analysis on Ximbio portfolio and determine growth strategiesCollaborated with Information Manager to develop Standard Operating Procedures (SOPs) for annual Revenue Share Reporting to Ximbio’s partnersDeveloped format for monthly reporting; collaborated with Ximbio Portfolio team to ensure adoption Managed product logistics and repositories.

Lead a 3-stage screening process that selects from among 15 early stage life science and medical device companies, subsequently presented to over 20 angel investors every quarter

Kirkland, Washington, Us

Prevencio is a Life Science diagnostics company developing cardiac biomarker panels for the diagnosis of various cardiovascular diseases (CAD, CVE, PAD, AS).Identified over 20 academic researchers in cardiovascular clinical trials and coordinated with Prevencio VP of Clinical Development, resulting in 3 academic partnerships for external validation of cardiac biomarkersDeveloped marketing materials, alongside the VP of Clinical Development

Olico Therapeutics is a team at UW developing novel agonistic antibodies by leveraging novel protein design technology to create therapies for cancer and previously untreatable diseases.Created customer discovery plan and strategic market analysis to identify 8 initial drug targets for therapeutic development and identifying corresponding key industry partnersUtilized existing networks to establish collaboration with a global pharmaceutical company for agonist therapeutic pipeline developmentDeveloped commercialization plan, business and financial models for initial commercialization steps

ecosVC® enables science and engineering innovators to translate their research into commercial innovations to meet market needs. Organized workshop logistics for Lens of the Market® training series and marketing for the Innovation Track at the 2017 American Chemical Society Northwest Regional MeetingData management for Lens of the Market® survey feedback

Seattle, Wa, Us

https://gardnerlab.org/Thesis Title: Ubiquitin-Mediated Regulation of RNA Polymerase I in Saccharomyces cerevisiaeManaged and performed experiments pertaining to projects involved in understanding both yeast and mammalian ubiquitin regulation of RNA polymerase I pertaining to uncovering novel therapeutic targetsMentored undergraduates in their research projectsFacilitated research collaborations with researchers at Johns Hopkins and University of Alabama-BirminghamManaged, planned, set deadlines, and prioritized tasks for personal scientific goals and lab projects; provided similar guidance to undergraduate researchers for over 5 years

Z-ion+ Technologies is developing a quasi-zwitterionic, non-stick coating that can be applied to any vascular medical device to decrease the risk of blood clot formation. Developed strategic market analysis for initial target markets being contemplated for commercializationCreated business plan and established scientific and business development milestones to be used for 2016 Business Plan Competition, resulting in winning the Cambia Grove's Best Healthcare Innovation Idea award Won funding through the Startup UW’s Bark Tank Best Pitch CompetitionWelcomed the responsibility of application to Health Innovation Challenge (2016), resulting in invitation to participate in prestigious competitionSet organizational goals to achieve 1st place prize for the Science and Technology Showcase (2016)Identified problems & developed solutions in creating proposal resulting in company’s selection for NSF-iCORP Funding (2016)

A Plus Pediatrics offers medical care to newborns and to 18 years of age.Gained an understanding of small scale medical practice decision making, insurance reimbursement procedures and how care gaps are closedWorked with patients and parents to gain accurate medical histories during sick and well examsAdministered vaccinations and maintain vaccine records for each patientProcessed referrals for patients to establish and maintain specialist careClosed care gaps maintain and grow patient rateTrained other medical assistants in ICD-9 and CPT coding to maintain proper billing for insurance companies

The Spine and Pain Institute of New York is dedicated to the diagnosis, treatment and management of acute and chronic pain. We strive to provide our patients with an accurate diagnosis to relieve pain utilizing the least invasive treatment methods. Gained an understanding of healthcare decision making in multi-practice settingPrepared patients for outpatient procedures including Epidural Steroid Injections, Medial Branch Blocks and Radiofrequency AblationsMaintained patients' medical historiesFollowed up with patients' after outpatient procedures

Allentown, Pa, Us

CRLA Level III

Doctor Of Philosophy (Phd), Pharmacology

Bachelor Of Science (B.S.), Biology

Education record